Amgen (AMGN) - Amgen's stock has experienced a 4% decline over the past week, with a current rating of 72% Strong Sell according to Barchart Technical Opinion [1] - The stock has shown a 3-7-D sequence over the past 10 weeks, indicating three up weeks and seven down weeks, which is a rare quantitative signal [6] - In the fourth week of this sequence, the probability of upside success is 65.5%, significantly higher than the baseline probability of 48.8% [7] - The 50th-percentile price under the 3-7-D pathway is projected to be around $277.50, suggesting a potential bullish trade with a 275/280 bull call spread expiring on October 24 [8] Enphase Energy (ENPH) - Enphase Energy's stock has seen a short interest of approximately 20% of its float, indicating potential for a short squeeze [9] - The stock has printed a 6-4-D sequence, with six up weeks and four down weeks, resulting in an overall negative trajectory despite recent gains [10] - Under the 6-4-D pathway, the odds of upside success are higher than normal, with a recommended trade being a 37/40 bull call spread expiring on October 24, which could yield a payout of nearly 142% [12] Dutch Bros (BROS) - Dutch Bros has shown a modest gain of 1.37% since the start of the year, but its stock performance has been highly volatile [13] - The stock is rated as an 88% Strong Sell by Barchart Technical Opinion, indicating high risk [14] - Dutch Bros has also printed a 3-7-D sequence, which has historically shown a 100% upside probability in certain weeks, although this should be viewed cautiously due to the small sample size [15] - A potential trade opportunity is identified with a 55/58 bull call spread expiring on October 31, which could yield a maximum payout of nearly 161% [16]